Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Dimitrov Website

Dimiter S. Dimitrov, Ph.D.

Selected Publications

1)  Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, Croix BS, Qian M, Dimitrov DS, Ho M.
A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface.
Mol. Cancer Ther. [Epub ahead of print], 2013.
[Journal]
2)  Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ.
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood. 121: 1165-74, 2013.
[Journal]
3)  Chen W, Ying T, Dimitrov DS.
Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.
Expert Opin Biol Ther. 13: 657-71, 2013.
[Journal]
4)  Zhu Z, Prabakaran P, Chen W, Broder CC, Gong R, Dimitrov DS.
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.
Virol Sin. 28: 71-80, 2013.
[Journal]
5)  Meyerson JR, Tran EE, Kuybeda O, Chen W, Dimitrov DS, Gorlani A, Verrips T, Lifson JD, Subramaniam S.
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives.
Proc. Natl. Acad. Sci. U.S.A. 110: 513-8, 2013.
[Journal]
6)  Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M.
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.
Proc. Natl. Acad. Sci. U.S.A. 110: E1083-91, 2013.
[Journal]
7)  Feng Y, Dimitrov DS.
Antibody-based therapeutics against components of the IGF system.
Oncoimmunology. 1: 1390-1391, 2012.
[Journal]
8)  Gong R, Wang Y, Ying T, Dimitrov DS.
Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn.
PLoS ONE. 7: e42288, 2012.
[Journal]
9)  Gong R, Chen W, Dimitrov DS.
Candidate Antibody-Based Therapeutics Against HIV-1.
BioDrugs. 26: 143-62, 2012.
[Journal]
10)  Varewijck AJ, Brugts MP, Frystyk J, Goudzwaard JA, Uitterlinden P, Waaijers AM, Feng Y, Dimitrov DS, Lamberts SW, Hofland LJ, Janssen JA.
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Mol. Cell. Endocrinol. [Epub ahead of print], 2012.
[Journal]
11)  Gong R, Chen W, Dimitrov DS.
Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains.
Methods Mol. Biol. 899: 85-102, 2012.
[Journal]
12)  Chen W, Feng Y, Wang Y, Zhu Z, Dimitrov DS.
Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies.
Biochem. Biophys. Res. Commun. [Epub ahead of print], 2012.
[Journal]
13)  Chen W, Feng Y, Zhao Q, Zhu Z, Dimitrov DS.
Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeutics.
Mol Cancer Ther. [Epub ahead of print], 2012.
[Journal]
14)  Zhang MY, Yuan T, Li J, Rosa Borges A, Watkins JD, Guenaga J, Yang Z, Wang Y, Wilson R, Li Y, Polonis VR, Pincus SH, Ruprecht RM, Dimitrov DS.
Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41.
PLoS ONE. 7: e44241, 2012.
[Journal]
15)  Chen W, Prabakaran P, Zhu Z, Feng Y, Streaker ED, Dimitrov DS.
Identification of cross-reactive IgG antibodies from an acute HIV-1-infected patient using phage display and high-throughput sequencing technologies.
Exp. Mol. Pathol. [Epub ahead of print], 2012.
[Journal]
16)  Prabakaran P, Zhu Z, Chen W, Gong R, Feng Y, Streaker E, Dimitrov DS.
Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing.
Front Microbiol. 3: 277, 2012.
[Journal]
17)  Gehlsen K, Gong R, Bramhill D, Wiersma D, Kirkpatrick S, Wang Y, Feng Y, Dimitrov DS.
Pharmacokinetics of engineered human monomeric and dimeric CH2 domains.
MAbs. 4: 466-74, 2012.
[Journal]
18)  Ying T, Chen W, Gong R, Feng Y, Dimitrov DS.
Soluble Monomeric IgG1 Fc.
J Biol Chem. [Epub ahead of print], 2012.
[Journal]
19)  Adler MJ, Dimitrov DS.
Therapeutic antibodies against cancer.
Hematol. Oncol. Clin. North Am. 26: 447-81, 2012.
[Journal]
20)  Dimitrov DS.
Therapeutic proteins.
Methods Mol. Biol. 899: 1-26, 2012.
[Journal]
21)  Zhao Q, Zhu Z, Dimitrov DS.
Yeast display of engineered antibody domains.
Methods Mol. Biol. 899: 73-84, 2012.
[Journal]
22)  Prabakaran P, Streaker E, Chen W, Dimitrov DS.
454 antibody sequencing - error characterization and correction.
BMC Res Notes. 4: 404, 2011.
[Journal]
23)  Feng Y, Shen J, Streaker ED, Lockwood M, Zhu Z, Low PS, Dimitrov DS.
A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity.
Arthritis Res Ther. 13: R59, 2011.
[Journal]
24)  Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, Rockx B.
A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.
Sci Transl Med. 3: 105ra103, 2011.
[Journal]
25)  Chen W, Streaker ED, Russ DE, Feng Y, Prabakaran P, Dimitrov DS.
Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens.
Biochem Biophys Res Commun. [Epub ahead of print], 2011.
[Journal]
26)  Gift SK, Zentner IJ, Schön A, McFadden K, Umashankara M, Rajagopal S, Contarino M, Duffy C, Courter JR, Zhang M, Gershoni JM, Cocklin S, Dimitrov DS, Smith AB, Freire E, Chaiken IM.
Conformational and Structural Features of HIV-1 gp120 Underlying Dual Receptor Antagonism by the Cross-Reactive Neutralizing Antibody, m18.
Biochemistry. [Epub ahead of print], 2011.
[Journal]
27)  Zhu Z, Qin HR, Chen W, Zhao Q, Shen X, Schutte R, Wang Y, Ofek G, Streaker E, Prabakaran P, Fouda GG, Liao H, Owens J, Louder M, Yang Y, Klaric K, Moody MA, Mascola JR, Scott JK, Kwong PD, Montefiori D, Haynes BF, Tomaras GD, Dimitrov DS.
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies.
J Virol. [Epub ahead of print], 2011.
[Journal]
28)  Feng Y, Gong R, Dimitrov DS.
Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor.
Protein Expr Purif. [Epub ahead of print], 2011.
[Journal]
29)  Chen W, Feng Y, Gong R, Zhu Z, Wang Y, Zhao Q, Dimitrov DS.
Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens.
J Virol. [Epub ahead of print], 2011.
[Journal]
30)  Prabakaran P, Chen W, Singarayan MG, Stewart CC, Streaker E, Feng Y, Dimitrov DS.
Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations.
Immunogenetics. [Epub ahead of print], 2011.
[Journal]
31)  Zhao Q, Feng Y, Zhu Z, Dimitrov DS.
Human Monoclonal Antibody Fragments Binding to Insulin-like Growth Factors 1 and 2 with Picomolar Affinity.
Mol Cancer Ther. [Epub ahead of print], 2011.
[Journal]
32)  Xiao X, Feng Y, Zhu Z, Dimitrov DS.
Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor.
Biochem Biophys Res Commun. [Epub ahead of print], 2011.
[Journal]
33)  Gift SK, McFadden K, Zentner IJ, Rajagopal S, Zhang MY, Dimitrov DS, Chaiken IM.
Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.
Biochemistry. 50: 2769-79, 2011.
[Journal]
34)  Chen W, Dimitrov DS.
Monoclonal antibody-based candidate therapeutics against HIV-1.
AIDS Res Hum Retroviruses. [Epub ahead of print], 2011.
[Journal]
35)  Yuan T, Li J, Zhang Y, Wang Y, Streaker E, Dimitrov DS, Zhang M.
Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development.
Vaccine. [Epub ahead of print], 2011.
[Journal]
36)  Gong R, Wang Y, Feng Y, Zhao Q, Dimitrov DS.
Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal receptor.
J Biol Chem. [Epub ahead of print], 2011.
[Journal]
37)  Chen W, Zhu Z, Feng Y, Dimitrov DS.
A large human domain antibody library combining heavy and light chain CDR3 diversity.
Mol. Immunol. 47(4): 912-21, 2010.
[Journal]
38)  Chen W, Xiao X, Wang Y, Zhu Z, Dimitrov DS.
Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates.
Antiviral research. 88(1): 107-15, 2010.
[Journal]
39)  Chen W, Zhu Z, Liao H, Quinnan GV, Broder CC, Haynes BF, Dimitrov DS.
Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins.
Viruses. 2: 547-565, 2010.
[Journal]
40)  Xiao X, Zhu Z, Dankmeyer JL, Wormald MM, Fast RL, Worsham PL, Cote CK, Amemiya K, Dimitrov DS.
Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model.
PLoS ONE. 5: e13047, 2010.
[Journal]
41)  Feng Y, Xiao X, Zhu Z, Dimitrov DS.
Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody.
MAbs. 2: 565-70, 2010.
[Journal]
42)  Zhang M, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS.
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.
MAbs. 2(3): 266-74, 2010.
[Journal]
43)  Loomis K, Smith B, Feng Y, Garg H, Yavlovich A, Campbell-Massa R, Dimitrov DS, Blumenthal R, Xiao X, Puri A.
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv.
Exp. Mol. Pathol. 88(2): 238-49, 2010.
[Journal]
44)  Dimitrov DS.
Therapeutic antibodies, vaccines and antibodyomes.
MAbs. 2(3): 347-56, 2010.
[Journal]
45)  Xiao X, Feng Y, Vu BK, Ishima R, Dimitrov DS.
A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors.
Biochem. Biophys. Res. Commun. 387: 387-92, 2009.
[Journal]
46)  Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan Y, Hickey AC, Dimitrov DS, Wang L, Broder CC.
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.
PLoS Pathog. 5(10): e1000642, 2009.
[Journal]
47)  Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, Pastan I, Dimitrov DS.
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity.
Mol. Cancer Ther. 2009.
[Journal]
48)  Lacy SE, Bond CJ, Benjamin D, Gerber HP, Dimitrov DS, Reichert JM.
Americas Antibody Congress: September 21-23, 2009, Washington, D.C.
MAbs. 1: 523-30, 2009.
[Journal]
49)  Zhang M, Feng Y, Wang Y, Dimitrov DS.
Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor.
MAbs. 1(5): 475-80, 2009.
[Journal]
50)  Zhang MY, Dimitrov DS.
Competitive Antigen Panning for Selection of HIV-1 Neutralizing Human Monoclonal Antibodies Specific for gp41.
Methods Mol. Biol. 525: 1-12, 2009.
[Journal]
51)  Chen W, Zhu Z, Xiao X, Dimitrov DS.
Construction of a human antibody domain (VH) library.
Methods Mol. Biol. 525: 81-99, xiii, 2009.
[Journal]
52)  Zhu Z, Dimitrov DS.
Construction of a large naïve human phage-displayed Fab library through one-step cloning.
Methods Mol. Biol. 525: 129-42, xv, 2009.
[Journal]
53)  Zhang MY, Wang Y, Mankowski MK, Ptak RG, Dimitrov DS.
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen.
Vaccine. 27: 857-63, 2009.
[Journal]
54)  Vu BK, Walsh JD, Dimitrov DS, Ishima R.
Dynamics of antibody domains studied by solution NMR.
Methods Mol. Biol. 525: 533-43, xv, 2009.
[Journal]
55)  Dimitrov DS.
Engineered CH2 domains (nanoantibodies).
MAbs. 1(1): 26-8, 2009.
[Journal]
56)  Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, Dimitrov DS.
Engineered human antibody constant domains with increased stability.
J. Biol. Chem. 284: 14203-10, 2009.
[Journal]
57)  Xiao X, Chen W, Feng Y, Zhu Z, Prabakaran P, Wang Y, Zhang MY, Longo NS, Dimitrov DS.
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.
Biochem. Biophys. Res. Commun. 390: 404-9, 2009.
[Journal]
58)  Chen W, Dimitrov DS.
Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors.
Curr Opin HIV AIDS. 4: 112-7, 2009.
[Journal]
59)  Xiao X, Ho M, Zhu Z, Pastan I, Dimitrov DS.
Identification and characterization of fully human anti-CD22 monoclonal antibodies.
MAbs. 1(3): 297-303, 2009.
[Journal]
60)  Ramakrishnan B, Boeggeman E, Manzoni M, Zhu Z, Loomis K, Puri A, Dimitrov DS, Qasba PK.
Multiple site-specific in vitro labeling of single-chain antibody.
Bioconjug. Chem. 20(7): 1383-9, 2009.
[Journal]
61)  Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS.
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.
Expert opinion on biological therapy. 9: 355-368, 2009.
[Journal]
62)  Feng Y, Dimitrov DS.
Scaling-up and production of therapeutic antibodies for preclinical studies.
Methods Mol. Biol. 525: 499-508, xiii, 2009.
[Journal]
63)  Zhang MY, Dimitrov DS.
Sequential Antigen Panning for Selection of Broadly Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies.
Methods Mol. Biol. 562: 143-54, 2009.
[Journal]
64)  Chen L, Do Kwon Y, Zhou T, Wu X, O'Dell S, Cavacini L, Hessell AJ, Pancera M, Tang M, Xu L, Yang ZY, Zhang MY, Arthos J, Burton DR, Dimitrov DS, Nabel GJ, Posner MR, Sodroski J, Wyatt R, Mascola JR, Kwong PD.
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120.
Science. 326: 1123-7, 2009.
[Journal]
65)  Kimura T, Kuwata T, Ashimine S, Yamazaki M, Yamauchi C, Nagai K, Ikehara A, Feng Y, Dimitrov DS, Saito S, Ochiai A.
Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment.
Clinical cancer research : an official journal of the American Association for Cancer Research. 16(1): 121-9, 2009.
[Journal]
66)  Dimitrov DS, Marks JD.
Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?.
Methods Mol. Biol. 525: 1-27, xiii, 2009.
[Journal]
67)  Chen W, Zhu Z, Feng Y, Xiao X, Dimitrov DS.
Construction of a Large Phage-Displayed Human Antibody Domain Library with a Scaffold Based On a Newly Identified Highly Soluble, Stable Heavy Chain Variable Domain.
J. Mol. Biol. 382(3): 779-89, 2008.
[Journal]
68)  Chen W, Zhu Z, Feng Y, Dimitrov DS.
Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers.
Proc. Natl. Acad. Sci. U.S.A. 105(44): 17121-6, 2008.
[Journal]
69)  Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, Zhu Z, Wang LF, Dimitrov DS, Broder CC.
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding.
J. Virol. 82: 11398-409, 2008.
[Journal]
70)  Prabakaran P, Vu BK, Gan J, Feng Y, Dimitrov DS, Ji X.
Structure of an isolated unglycosylated antibody C(H)2 domain.
Acta Crystallogr. D Biol. Crystallogr. 64: 1062-7, 2008.
[Journal]
71)  Zhang M, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, Alam M, Ruprecht RM, Quinnan G, Jiang S, Montefiori DC, Mascola JR, Broder CC, Haynes BF, Dimitrov DS.
Cross-Reactive Human Immunodeficiency Virus Type 1- Neutralizing Human Monoclonal Antibody which Recognizes A Novel Conformational Epitope on gp41 and Lacks Reactivity against Self Antigens.
J. Virol. 82: 6869-79, 2008.
[Journal]
72)  Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang L, Broder CC, Dimitrov DS.
Exceptionally Potent Cross-Reactive Neutralization of Nipah and Hendra Viruses by a Human Monoclonal Antibody.
J. Infect. Dis. 197(6): 846-53, 2008.
[Journal]
73)  Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, Broder CC, Wang L.
Functional studies of host-specific ephrin-B ligands as Henipavirus receptors.
Virology. 372(2): 357-71, 2008.
[Journal]
74)  Epand RF, Zhang Y, Mirzabekov T, Kagan B, Silberstein A, Hubbell WL, Epand RM, Chakraborti S, Dimitrov DS, Anderson WF, Rozenberg-Adler Y.
Membrane activity of an amphiphilic alpha-Helical membrane-proximal cytoplasmic domain of the MoMuLV envelope glycoprotein.
Exp Mol Pathol. 84(1): 9-17, 2008.
[Journal]
75)  Rozenberg-Adler Y, Conner J, Aguilar-Carreno H, Chakraborti S, Dimitrov DS, Anderson WF.
Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion.
Exp Mol Pathol. 84(1): 18-30, 2008.
[Journal]
76)  Feng Y, Dimitrov DS.
Monoclonal antibodies against components of the IGF system for cancer treatment.
Curr Opin Drug Discov Devel. 11: 178-85, 2008.
[Journal]
77)  Polonis VR, Brown BK, Borges AR, Zolla-Pazner S, Dimitrov DS, Zhang M, Barnett SW, Ruprecht RM, Scarlatti G, Fenyo E, Montefiori DC, McCutchan FE, Michael NL.
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
Virology. 375: 315-20, 2008.
[Journal]
78)  Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS.
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
Virology. 363: 79-90, 2007.
[Journal]
79)  Jimenez-Baranda S, Gomez-Mouton C, Rojas A, Martinez-Prats L, Mira E, Ana Lacalle R, Valencia A, Dimitrov DS, Viola A, Delgado R, Martinez-A C, Manes S.
Filamin-A regulates actin-dependent clustering of HIV receptors.
Nat Cell Biol. 9(7): 838-46, 2007.
[Journal]
80)  Yu L, Zhu Z, Chan KC, Issaq HJ, Dimitrov DS, Veenstra TD.
Improved Titanium Dioxide Enrichment of Phosphopeptides from HeLa Cells and High Confident Phosphopeptide Identification by Cross-Validation of MS/MS and MS/MS/MS Spectra.
J Proteome Res. 6(11): 4150-62, 2007.
[Journal]
81)  Dimitrov DS, Wang LF.
In utero transmission of nipah virus: role played by pregnancy and vertical transmission in henipavirus epidemiology.
J. Infect. Dis. 196: 807-9, 2007.
[Journal]
82)  Xiao X, Dimitrov DS.
Monoclonal antibodies against viruses and bacteria: a survey of patents.
Recent Patents Anti-Infect Drug Disc. 2: 171-7, 2007.
[Journal]
83)  Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, Wang LF.
Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
J. Virol. Methods. 142: 29-40, 2007.
[Journal]
84)  Zhang MY, Dimitrov DS.
Novel Approaches for Identification of Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies and Improvement of Their Potency.
Curr. Pharm. Des. 13: 203-12, 2007.
[Journal]
85)  Zhu Z, Chakraborti S, He Y, Roberts A, Sheahan T, Xiao X, Hensley LE, Prabakaran P, Rockx B, Sidorov IA, Corti D, Vogel L, Feng Y, Kim JO, Wang LF, Baric R, Lanzavecchia A, Curtis KM, Nabel GJ, Subbarao K, Jiang S, Dimitrov DS.
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
Proc. Natl. Acad. Sci. U.S.A. 104: 12123-8, 2007.
[Journal]
86)  Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD.
Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Nature. 445: 732-7, 2007.
[Journal]
87)  Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS.
Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors.
Adv. Pharmacol. 55: 33-97, 2007.
[Journal]
88)  Blumenthal R, Dimitrov DS.
Targeting the Sticky Fingers of HIV-1.
Cell. 129: 243-5, 2007.
[Journal]
89)  Sidorov I, Blumenthal R, Dimitrov D.
A model of drug delivery to normal and cancer cells by antibody-targeted nanoliposomes.
J. Comp. & Theor. Nanosci. 3: 405-11, 2006.
[Journal]
90)  Choudhry V, Zhang MY, Dimitrova D, Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS.
Antibody-based inhibitors of HIV infection.
Expert Opin Biol Ther. 6: 523-31, 2006.
[Journal]
91)  Zhou T, Xu L, Dey B, Hessell AJ, Majeed S, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD.
Design clues from functional constraints and broadly neutralizing antibodies.
Retrovirology. 3 Suppl 1: S22, 2006.
[Journal]
92)  Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, Dimitrov DS.
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.
Expert Rev Anti Infect Ther. 4: 57-66, 2006.
[Journal]
93)  Zhang MY, Vu B, Huang CC, Sidirov I, Choudhly V, Kwong PD, Dimitrov DS.
Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors.
Retrovirology. 3 Suppl 1: S61, 2006.
[Journal]
94)  Choudhry V, Zhang MY, Harris I, Sidorov IA, Vu B, Dimitrov AS, Fouts T, Dimitrov DS.
Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.
Biochem. Biophys. Res. Commun. 348: 1107-15, 2006.
[Journal]
95)  Di Mascio M, Sereti I, Matthews LT, Natarajan V, Adelsberger J, Lempicki R, Yoder C, Jones E, Chow C, Metcalf JA, Sidorov IA, Dimitrov DS, Polis MA, Kovacs JA.
Naive T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
J Virol. 80: 2665-74, 2006.
[Journal]
96)  Feng Y, Zhu Z, Xiao X, Choudhry V, Barrett JC, Dimitrov DS.
Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function.
Mol Cancer Ther. 5: 114-20, 2006.
[Journal]
97)  Feng Y, Yuan JH, Maloid SC, Fisher R, Copeland TD, Longo DL, Conrads TP, Veenstra TD, Ferris A, Hughes S, Dimitrov DS, Ferris DK.
Polo-like kinase 1-mediated phosphorylation of the GTP-binding protein Ran is important for bipolar spindle formation.
Biochem. Biophys. Res. Commun. 349: 144-52, 2006.
[Journal]
98)  Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, Dimitrov DS.
Potent neutralization of hendra and nipah viruses by human monoclonal antibodies.
J Virol. 80: 891-9, 2006.
[Journal]
99)  Zhang MY, Choudhry V, Sidorov IA, Tenev V, Vu BK, Choudhary A, Lu H, Stiegler GM, Katinger HW, Jiang S, Broder CC, Dimitrov DS.
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.
J. Immunol. Methods. 317: 21-30, 2006.
[Journal]
100)  Prabakaran P, Gan J, Wu Y, Zhang M, Dimitrov DS, Ji X.
Structural Mimicry of CD4 by a Cross-reactive HIV-1 Neutralizing Antibody with CDR-H2 and H3 Containing Unique Motifs.
J Mol Biol. 357(1): 82-99, 2006.
[Journal]
101)  Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS.
Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.
J. Biol. Chem. 281: 15829-36, 2006.
[Journal]
102)  Patton GW, Stephens R, Sidorov IA, Xiao X, Lempicki RA, Dimitrov DS, Shoemaker RH, Tudor G.
Transcriptomic response to differentiation induction.
BMC Bioinformatics. 7: 81, 2006.
[Journal]
103)  Zhang MY, Choudhry V, Xiao X, Dimitrov DS.
Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS.
Curr Opin Mol Ther. 7: 151-6, 2005.
[Journal]
104)  Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC.
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.
Proc Natl Acad Sci U S A. 102(30): 10652-7, 2005.
[Journal]
105)  Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Sereti I, Sachau W, Kelly G, Metcalf JA, Davey RT, Falloon J, Polis MA, Tavel J, Stevens R, Lambert L, Hosack DA, Bosche M, Issaq HJ, Fox SD, Leitman S, Baseler MW, Masur H, Di Mascio M, Dimitrov DS, Lane HC.
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
J. Clin. Invest. 115: 2139-48, 2005.
[Journal]
106)  Sloane AJ, Raso V, Dimitrov DS, Xiao X, Deo S, Muljadi N, Restuccia D, Turville S, Kearney C, Broder CC, Zoellner H, Cunningham AL, Bendall L, Lynch GW.
Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-1alpha responses.
Immunol Cell Biol. 83: 129-43, 2005.
[Journal]
107)  Xiao X, Sidorov IA, Gee J, Lempicki RA, Dimitrov DS.
Retinoic acid-induced downmodulation of telomerase activity in human cancer cells.
Exp Mol Pathol. 79(2): 108-17, 2005.
[Journal]
108)  Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, Wyatt R, Kwong PD.
Structure of a V3-Containing HIV-1 gp120 Core.
Science. 310: 1025-8, 2005.
[Journal]
109)  Chakraborti S, Prabakaran P, Xiao X, Dimitrov DS.
The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization.
Virol J. 2: 73, 2005.
[Journal]
110)  Sidorov IA, Gee D, Dimitrov DS.
A kinetic model of telomere shortening in infants and adults.
J Theor Biol. 226: 169-75, 2004.
[Journal]
111)  Prabakaran P, Xiao X, Dimitrov DS.
A model of the ACE2 structure and function as a SARS-CoV receptor.
Biochem Biophys Res Commun. 314: 235-41, 2004.
[Journal]
112)  Xiao X, Dimitrov DS.
Cell biology of virus entry: a review of the 4th International Frederick Meeting.
Mol Membr Biol. 21: 281-7, 2004.
[Journal]
113)  Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X.
Crystal Structure of the Broadly Cross-Reactive HIV-1-Neutralizing Fab X5 and Fine Mapping of Its Epitope(,).
Biochemistry. 43: 1410-1417, 2004.
[Journal]
114)  Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS.
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
J Virol. 78: 9233-42, 2004.
[Journal]
115)  Zhang MY, Shu Y, Sidorov I, Dimitrov DS.
Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades.
Antiviral Res. 61: 161-4, 2004.
[Journal]
116)  Zhang MY, Shu Y, Rudolph D, Prabakaran P, Labrijn AF, Zwick MB, Lal RB, Dimitrov DS.
Improved Breadth and Potency of an HIV-1-Neutralizing Human Single-chain Antibody by Random Mutagenesis and Sequential Antigen Panning.
J Mol Biol. 335: 209-19, 2004.
[Journal]
117)  Moulard M, Zhang MY, Dimitrov DS.
Novel HIV neutralizing antibodies selected from phage display libraries.
In: Antibodies (Subramanian, G., ed), Kluwer, New York. 2: 105-117, 2004.
[Journal]
118)  Xiao X, Feng Y, Chakraborti S, Dimitrov DS.
Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain.
Biochem Biophys Res Commun. 322: 93-9, 2004.
[Journal]
119)  Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S, Zhang MY, Dimitrov DS, Hendrickson WA, Robinson J, Sodroski J, Wyatt R, Choe H, Farzan M, Kwong PD.
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.
Proc Natl Acad Sci U S A. 101: 2706-11, 2004.
[Journal]
120)  Huentelman MJ, Zubcevic J, Hernández Prada JA, Xiao X, Dimitrov DS, Raizada MK, Ostrov DA.
Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.
Hypertension. 44: 903-6, 2004.
[Journal]
121)  Xiao X, Dimitrov DS.
The SARS-CoV S glycoprotein.
Cell Mol Life Sci. 61: 2428-30, 2004.
[Journal]
122)  Dimitrov DS.
Virus entry: molecular mechanisms and biomedical applications.
Nature Reviews Microbiology. 2: 109-122, 2004.
[Journal]
123)  Labrijn AF, Poignard P, Raja A, Zwick MB, Delgado K, Franti M, Binley J, Vivona V, Grundner C, Huang CC, Venturi M, Petropoulos CJ, Wrin T, Dimitrov DS, Robinson J, Kwong PD, Wyatt RT, Sodroski J, Burton DR.
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.
J Virol. 77: 10557-65, 2003.
[Journal]
124)  Klein SM, Dimitrov D, Steele SM, Nielsen KC, Warner DS, Martin A, Pietrobon R.
Altered perceptions after upper and lower extremity blocks: an initial investigation.
Reg Anesth Pain Med. 28: 433-8, 2003.
[Journal]
125)  Zhang MY, Shu Y, Phogat S, Xiao X, Cham F, Bouma P, Choudhary A, Feng YR, Sanz I, Rybak S, Broder CC, Quinnan GV, Evans T, Dimitrov DS.
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.
J Immunol Methods. 283: 17-25, 2003.
[Journal]
126)  Sidorov IA, Hirsch KS, Harley CB, Dimitrov DS.
Cancer treatment by telomerase inhibitors: predictions by a kinetic model.
Math Biosci. 181: 209-21, 2003.
[Journal]
127)  Phogat SK, Dimitrov DS.
Cell biology of virus entry: a review of selected topics from the 3rd International Frederick meeting.
Biochim Biophys Acta. 1614: 85-8, 2003.
[Journal]
128)  Leavitt M, Park EJ, Sidorov IA, Dimitrov DS, Quinnan GV.
Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.
J Virol. 77: 560-70, 2003.
[Journal]
129)  Tan PK, Downey TJ, Spitznagel EL, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM, Cam MC.
Evaluation of gene expression measurements from commercial microarray platforms.
Nucleic Acids Res. 31: 5676-84, 2003.
[Journal]
130)  Staudinger R, Phogat SK, Xiao X, Wang X, Dimitrov DS, Zolla-Pazner S.
Evidence for CD4-enchanced signaling through the chemokine receptor CCR5.
J Biol Chem. 278: 10389-92, 2003.
[Journal]
131)  Bouma P, Leavitt M, Zhang PF, Sidorov IA, Dimitrov DS, Quinnan GV.
Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1.
J Virol. 77: 8061-71, 2003.
[Journal]
132)  Xiao X, Phogat S, Shu Y, Phogat A, Chow YH, Wei OL, Goldstein H, Broder CC, Dimitrov DS.
Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
Vaccine. 21: 4275-84, 2003.
[Journal]
133)  Xiao X, Athanasiou M, Sidorov IA, Horikawa I, Cremona G, Blair D, Barret JC, Dimitrov DS.
Role of Ets/Id proteins for telomerase regulation in human cancer cells.
Exp Mol Pathol. 75: 238-47, 2003.
[Journal]
134)  Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS.
The SARS-CoV S glycoprotein: expression and functional characterization.
Biochem Biophys Res Commun. 312: 1159-64, 2003.
[Journal]
135)  Dimitrov DS.
The Secret Life of ACE2 as a Receptor for the SARS Virus.
Cell. 115: 652-3, 2003.
[Journal]
136)  Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS.
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Proc Natl Acad Sci U S A. 99: 6913-8, 2002.
[Journal]
137)  Sidorov IA, Hirsch KS, Harley CB, Dimitrov DS.
Cancer cell dynamics in presence of telomerase inhibitors: analysis of in vitro data.
J Theor Biol. 219: 225-33, 2002.
[Journal]
138)  Chow YH, Wei OL, Phogat S, Sidorov IA, Fouts TR, Broder CC, Dimitrov DS.
Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogens.
Biochemistry. 41: 7176-82, 2002.
[Journal]
139)  Cristillo AD, Xiao X, Campbell-Malone R, Dimitrov DS, Bierer BE.
Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expression.
Exp Mol Pathol. 73: 9-18, 2002.
[Journal]
140)  Golding H, Zaitseva M, de Rosny E, King LR, Manischewitz J, Sidorov I, Gorny MK, Zolla-Pazner S, Dimitrov DS, Weiss CD.
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
J Virol. 76: 6780-90, 2002.
[Journal]
141)  Biragyn A, Belyakov IM, Chow YH, Dimitrov DS, Berzofsky JA, Kwak LW.
DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses.
Blood. 100: 1153-9, 2002.
[Journal]
142)  Xiao X, Phogat SK, Sidorov IA, Yang J, Horikawa I, Prieto D, Adelesberger J, Lempicki R, Barrett JC, Dimitrov DS.
Identification and characterization of rapidly dividing U937 clones with differential telomerase activity and gene expression profiles: role of c-Myc/Mad1 and Id/Ets proteins.
Leukemia. 16: 1877-80, 2002.
[Journal]
143)  Sidorov IA, Hosack DA, Gee D, Yang J, Cam MC, Lempicki RA, Dimitrov DS.
Oligonucleotide microarray data distribution and normalization.
Information Sci. 146(1-4): 65-71, 2002.
[Journal]
144)  Peng B, Voltan R, Lim L, Edghill-Smith Y, Phogat S, Dimitrov DS, Arora K, Leno M, Than S, Woodward R, Markham PD, Cranage M, Robert-Guroff M.
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.
J Virol. 76: 6016-26, 2002.
[Journal]
145)  Cristillo AD, Highbarger HC, Dewar RL, Dimitrov DS, Golding H, Bierer BE.
Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element.
FASEB J. 16: 354-64, 2002.
[Journal]
146)  Polis MA, Sidorov IA, Yoder C, Jankelevich S, Metcalf J, Mueller BU, Dimitrov MA, Pizzo P, Yarchoan R, Dimitrov DS.
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy.
Lancet. 358: 1760-5, 2001.
[Journal]
147)  Dimitrov AS, Xiao X, Dimitrov DS, Blumenthal R.
Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.
J Biol Chem. 276: 30335-41, 2001.
[Journal]
148)  Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, Metcalf JA, Sereti I, Polis MA, Davey RT, Tavel J, Falloon J, Stevens R, Lambert L, Dewar R, Schwartzentruber DJ, Anver MR, Baseler MW, Masur H, Dimitrov DS, Lane HC.
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.
J Exp Med. 194: 1731-41, 2001.
[Journal]
149)  Dimitrov DS.
Cell biology of virus entry.
Cell. 101: 697-702, 2000.
[Journal]
150)  Shen W, Li B, Wetzel MA, Rogers TJ, Henderson EE, Su SB, Gong W, Le Y, Sargeant R, Dimitrov DS, Oppenheim JJ, Wang JM.
Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes.
Blood. 96: 2887-94, 2000.
[Journal]
151)  Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R.
Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
J Virol. 74: 6377-85, 2000.
[Journal]
152)  Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, Natarajan V, Bosche MC, Metcalf JA, Stevens RA, Lambert LA, Alvord WG, Polis MA, Davey RT, Dimitrov DS, Lane HC.
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.
Proc Natl Acad Sci U S A. 97: 13778-83, 2000.
[Journal]
153)  Xiao X, Norwood D, Feng YR, Moriuchi M, Jones-Trower A, Stantchev TS, Moriuchi H, Broder CC, Dimitrov DS.
Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
Exp Mol Pathol. 68: 139-46, 2000.
[Journal]
154)  Xiao X, Kinter A, Broder CC, Dimitrov DS.
Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Exp Mol Pathol. 68: 133-8, 2000.
[Journal]
155)  Chabot DJ, Chen H, Dimitrov DS, Broder CC.
N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.
J Virol. 74: 4404-13, 2000.
[Journal]
156)  Endo Y, Igarashi T, Nishimura Y, Buckler C, Buckler-White A, Plishka R, Dimitrov DS, Martin MA.
Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
J Virol. 74: 6935-45, 2000.
[Journal]
157)  Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC.
A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
Virology. 259: 1-6, 1999.
[Journal]
158)  Xiao X, Wu L, Stantchev TS, Feng YR, Ugolini S, Chen H, Shen Z, Riley JL, Broder CC, Sattentau QJ, Dimitrov DS.
Constitutive cell surface association between CD4 and CCR5.
Proc Natl Acad Sci U S A. 96: 7496-501, 1999.
[Journal]
159)  Davey RT, Bhat N, Yoder C, Chun TW, Metcalf JA, Dewar R, Natarajan V, Lempicki RA, Adelsberger JW, Miller KD, Kovacs JA, Polis MA, Walker RE, Falloon J, Masur H, Gee D, Baseler M, Dimitrov DS, Fauci AS, Lane HC.
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.
Proc Natl Acad Sci U S A. 96: 15109-14, 1999.
[Journal]
160)  Igarashi T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, Shibata R.
Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma.
Nature Medicine. 5(2): 211-6, 1999.
[Journal]
161)  Golding H, Ouyang J, Zaitseva M, Broder CC, Dimitrov DS, Lapham C.
Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies.
AIDS Res Hum Retroviruses. 15: 149-59, 1999.
[Journal]
162)  Feng YR, Biggar RJ, Gee D, Norwood D, Zeichner SL, Dimitrov DS.
Long-term telomere dynamics: modest increase of cell turnover in HIV-infected individuals followed for up to 14 years.
Pathobiology. 67: 34-8, 1999.
[Journal]
163)  Grossman Z, Polis M, Feinberg MB, Grossman Z, Levi I, Jankelevich S, Yarchoan R, Boon J, de Wolf F, Lange JM, Goudsmit J, Dimitrov DS, Paul WE.
Ongoing HIV dissemination during HAART.
Nat Med. 5: 1099-104, 1999.
[Journal]
164)  Zeichner SL, Palumbo P, Feng Y, Xiao X, Gee D, Sleasman J, Goodenow M, Biggar R, Dimitrov DS.
Rapid shortening of telomeres in children.
Blood. 93(9): 2824-30, 1999.
[Journal]
165)  Grossman Z, Herberman R, Dimitrov DS.
T cell turnover in SIV infection.
Science. 284: 555a-b, 1999.
[Journal]
166)  Shibata R, Feng YR, Gee D, Norwood D, Xiao X, Zeichner SL, Martin MA, Dimitrov DS.
Telomere dynamics in monkeys: increased cell turnover in macaques infected with chimeric simian-human immunodeficiency viruses.
J Med Primatol. 28: 1-10, 1999.
[Journal]
167)  Agosto M, Allan J, Benson C, Berger EA, Blumenthal R, Burton D, Clements J, Coffin J, Connor R, Cullen B, Desrosiers R, Dimitrov D.
AIDS vaccine development.
Science. 280: 803-05, 1998.
[Journal]
168)  Dimitrov DS, Xiao X, Chabot DJ, Broder CC.
HIV coreceptors.
J Membr Biol. 166: 75-90, 1998.
[Journal]
169)  Grossman Z, Feinber M, Kuznetsov V, Dimitrov DS, Paul WE.
HIV infection: how effective is drug treatment?.
Immunol. Today. 19: 528-32, 1998.
[Journal]
170)  Mueller BU, Zeichner SL, Kuznetsov VA, Heath-Chiozzi M, Pizzo PA, Dimitrov DS.
Individual prognoses of long-term responses to antiretroviral treatment based on virological, immunological and pharmacological parameters measured during the first week under therapy.
AIDS. 12: F191-6, 1998.
[Journal]
171)  Norwood D, Dimitrov DS.
Sensitive method for measuring telomere lengths by quantifying telomeric DNA content of whole cells.
Biotechniques. 25: 1040-5, 1998.
[Journal]
172)  Feng YR, Norwood D, Shibata R, Gee D, Xiao X, Martin M, Zeichner SL, Dimitrov DS.
Telomere dynamics in HIV-1 infected and uninfected chimpanzees measured by an improved method based on high-resolution two-dimensional calibration of DNA sizes.
J Med Primatol. 27: 258-65, 1998.
[Journal]
173)  Lowy RJ, Dimitrov DS.
Characterization of influenza virus-induced death of J774.1 macrophages.
Exp Cell Res. 234: 249-58, 1997.
[Journal]
174)  Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS, Gress RE.
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.
Blood. 89: 3700-7, 1997.
[Journal]
175)  Lee S, Peden K, Dimitrov DS, Broder CC, Manischewitz J, Denisova G, Gershoni JM, Golding H.
Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
J Virol. 71: 6037-43, 1997.
[Journal]
176)  Dimitrov DS.
How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity.
Cell. 91: 721-30, 1997.
[Journal]
177)  Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H.
Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.
Science. 274: 602-5, 1996.
[Journal]
178)  Dimitrov DS.
Fusin--a place for HIV-1 and T4 cells to meet.
Nat Med. 2: 640-1, 1996.
[Journal]
179)  Broder CC, Dimitrov DS.
HIV and the 7-transmembrane domain receptors.
Pathobiology. 64: 171-9, 1996.
[Journal]
180)  Spouge JI, Shrager RI, Dimitrov DS.
HIV-1 infection kinetics in tissue cultures.
Math Biosci. 138: 1-22, 1996.
[Journal]
181)  Zeichner SL, Mueller BU, Pizzo PA, Dimitrov DS.
Kinetics of HIV-1 RNA concentration changes in pediatric patients.
Pathobiology. 64: 289-94, 1996.
[Journal]
182)  Dimitrov DS, Apostolova MA.
The limit of PCR amplification.
J Theor Biol. 178: 425-6, 1996.
[Journal]
183)  Dimitrov DS, Martin MA.
HIV results in the frame. CD4+ cell turnover.
Nature. 375: 194-5; author reply 198, 1995.
[Journal]
184)  Golding H, Dimitrov DS, Manischewitz J, Broder CC, Robinson J, Fabian S, Littman DR, Lapham CK.
Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.
J Virol. 69: 6140-8, 1995.
[Journal]
185)  Burkly L, Mulrey N, Blumenthal R, Dimitrov DS.
Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
J Virol. 69: 4267-73, 1995.
[Journal]
186)  Elson HF, Dimitrov DS, Blumenthal R.
A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
Mol Membr Biol. 11: 165-9, 1994.
[Journal]
187)  Vicenzi E, Dimitrov DS, Engelman A, Migone TS, Purcell DF, Leonard J, Englund G, Martin MA.
An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.
J Virol. 68: 7879-90, 1994.
[Journal]
188)  Dimitrov DS, Blumenthal R.
Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency virus type 1 envelope glycoprotein.
J Virol. 68: 1956-61, 1994.
[Journal]
189)  Golding H, Manischewitz J, Vujcic L, Blumenthal R, Dimitrov DS.
The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
J Virol. 68: 1962-9, 1994.
[Journal]
190)  Puri A, Krumbiegel M, Dimitrov D, Blumenthal R.
A new approach to measure fusion activity of cloned viral envelope proteins: Fluorescence dequenching of octadecylrhodamine labeled plasma membrane vesicles fusing with cells expressing vesicular stomatitis virus glycoprotein.
Virology. 195: 855-58, 1993.
[Journal]
191)  Dimitrov DS, Broder CC, Berger EA, Blumenthal R.
Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction.
J Virol. 67: 1647-52, 1993.
[Journal]
192)  Golding H, Blumenthal R, Manischewitz J, Littman DR, Dimitrov DS.
Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.
J Virol. 67: 6469-75, 1993.
[Journal]
193)  Golding H, Dimitrov DS, Blackburn R, Manischewitz J, Blumenthal R, Golding B.
Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
J Immunol. 150: 2506-16, 1993.
[Journal]
194)  Dimitrov DS.
HIV-1 infection of cells and AIDS progression.
Biomed. Rev. 2: 1-8, 1993.
[Journal]
195)  Dimitrov DS.
Kinetic mechanisms of membrane fusion mediated by electric fields.
Bioelectrochemistry and Bioenergetics. 32: 99-124, 1993.
[Journal]
196)  Dimitrov DS, Franzoso G, Salman M, Blumenthal R, Tarshis M, Barile MF, Rottem S.
Mycoplasma fermentans (incognitus strain) cells are able to fuse with T lymphocytes.
Clin Infect Dis. 17 Suppl 1: S305-8, 1993.
[Journal]
197)  Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA.
Quantitation of human immunodeficiency virus type 1 infection kinetics.
J Virol. 67: 2182-90, 1993.
[Journal]
198)  Broder CC, Dimitrov DS, Blumenthal R, Berger EA.
The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
Virology. 193: 483-91, 1993.
[Journal]
199)  Sato H, Ornstein J, Dimitrov DS, Martin M.
Cell-to-cell spread of HIV-1 occurs within minutes and may not involve participation of virus particles.
Virology. 186: 712-24, 1992.
[Journal]
200)  Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, Golding H.
Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
AIDS. 6: 249-56, 1992.
[Journal]
201)  Krumbiegel M, Dimitrov DS, Puri A, Blumenthal R.
Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells.
Biochim Biophys Acta. 1110: 158-64, 1992.
[Journal]
202)  Franzoso G, Dimitrov DS, Blumenthal R, Barile MF, Rottem S.
Fusion of Mycoplasma fermentans strain incognitus with T-lymphocytes.
FEBS Lett. 303: 251-4, 1992.
[Journal]
203)  Puri A, Dimitrov DS, Golding H, Blumenthal R.
Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoprotein-expressing cells.
J Acquir Immune Defic Syndr. 5: 915-20, 1992.
[Journal]
204)  Dimitrov DS, Willey RL, Martin MA, Blumenthal R.
Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells.
Virology. 187: 398-406, 1992.
[Journal]
205)  Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, Golding H.
Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
J Virol. 66: 132-8, 1992.
[Journal]
206)  Golding H, Dimitrov DS, Blumenthal R.
LFA-1 adhesion molecules are not involved in early stages of HIV-1-env-mediated cell membrane fusion.
AIDS Res. Human Retroviruses. 8: 1607-12, 1992.
[Journal]
207)  Golding H, Dimitrov DS, Blumenthal R.
LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion.
AIDS Res Hum Retroviruses. 8: 1593-8, 1992.
[Journal]
208)  Dimitrov DS, Golding H, Blumenthal R.
Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
AIDS Res Hum Retroviruses. 7: 799-805, 1991.
[Journal]
209)  Zhelev DV, Zuzmin P, Dimitrov DS.
Mutual dielectrophoresis of cells.
Bioelectrochemistry and Bioenergetics. 26: 193-203, 1991.
[Journal]
210)  Dimitrov DS, Sowers AE.
A delay in membrane fusion: lag times observed by fluorescence microscopy of individual fusion events induced by an electric field pulse.
Biochemistry. 29: 8337-44, 1990.
[Journal]
211)  Dimitrov DS, Apostolova MA, Sowers AE.
Attraction, deformation and contact of membranes induced by low frequency electric fields.
Biochim Biophys Acta. 1023: 389-97, 1990.
[Journal]
212)  Dimitrov DS, Sowers AE.
Membrane electroporation--fast molecular exchange by electroosmosis.
Biochim Biophys Acta. 1022: 381-92, 1990.
[Journal]
213)  Dimitrov DS, Doinov P.
Biophysical engineering in biotechnology.
Biotechnology and Chemistry. 1: 1-9, 1989.
[Journal]
214)  Dimitrov DS, Doinov P.
Dielectrophoresis, instability and electrofusion in membrane systems.
J. Colloid Polymer Sci. 79: 1-5, 1989.
[Journal]
215)  Tsoneva I, Doinov P, Dimitrov DS.
Electrofusion of fragile mutants of Saccharomyces cerevisiae.
FEMS Microbiol Lett. 51: 61-5, 1989.
[Journal]
216)  Zhelev DV, Dimitrov DS.
Electrofusion of pea protoplasts in polyethylene glycol solutions.
Studia Biophysica. 130: 165-68, 1989.
[Journal]
217)  Doinov P, Stoicheva N, Dimitrov DS.
Polarizailities and densities of individual protoplasts: experimental methods and results.
Studia Biophysica. 130: 169-72, 1989.
[Journal]
218)  Angelova M, Dimitrov DS.
A mechanism of liposome electroformation.
Prog. Colloid Polymer Sci. 76: 67-76, 1988.
[Journal]
219)  Zhelev DV, Dimitrov DS, Doinov P.
Correlation between physical parameters in electrofusion and electroporation of protoplasts.
Bioelectrochemistry and Bioenergetics. 20: 155-67, 1988.
[Journal]
220)  Zhelev DV, Dimitrov DS, Tsoneva I.
Electrical breakdown of protoplasts membranes under different osmotic pressures.
Bioelectrochemistry and Bioenergetics. 19: 217-25, 1988.
[Journal]
221)  Dimitrov DS, Zhelev D.
Fluctuation wave mechanism of membrane electrofusion.
Prog. Colloid Polymer Sci. 76: 26-31, 1988.
[Journal]
222)  Tsoneva I, Panova I, Doinov P, Dimitrov DS, Strahilov D.
Hybridoma production by electrofusion: monoclonal antibodies against the Hc antigene of salmonella.
Studia Biophysica. 125: 31-5, 1988.
[Journal]
223)  Dimitrov DS, Angelova M.
Lipid swelling and liposome formation mediated by electic fields.
Bioelectrochemistry and Bioenergetics. 19: 323-36, 1988.
[Journal]
224)  Ivanov IB, Dimitrov DS.
Thin film drainage.
Thin Liquid Films. In: Ivanov IB (Ed): 379-496, 1988.
[Journal]
225)  Dimitrov DS, Zhelev DV.
Dielectrophoresis of individual cells. Experimental methods and results.
Bioelectrochemistry and Bioenergetics. 17: 549-57, 1987.
[Journal]
226)  Dimitrov DS, Angelova M.
Electric field mediated lipid swelling and electroswelling.
Studia Biophysica. 119: 61-65, 1987.
[Journal]
227)  Zhelev DV, Dimitrov DS, Tsoneva I.
Electrical breakdown of protoplasts in solutions of different osmolarity.
Studia Biophysica. 119: 53-56, 1987.
[Journal]
228)  Zhelev DV, Dimitrov DS.
Instability to rupture of anisotropic viscoelastic membranes: Dispersion equation and effects of surface elasticity and viscosity.
Molecular Crystals and Liquid Crystals. 152: 279-91, 1987.
[Journal]
229)  Angelova M, Dimitrov DS.
Liposome electroformation.
Faraday Discussions of the Chemical Society. 81: 303-11, 1987.
[Journal]
230)  Dimitrov DS, Tomov V, Sharkov G, Angelova M.
Liposome production and protoplast electrofusion expert systems.
Proceedings of the Artificial Intelligence and Machine Simulations Association 86. 219-28, 1987.
[Journal]
231)  Dimitrov DS, Zhelev D.
Single cell dielectrophoresis. Dynamic methods.
Studia Biophysica. 119: 57-60, 1987.
[Journal]
232)  Angelova M, Dimitrov DS.
Swelling of charged lipids and formation of liposomes on electrode surfaces.
Molecular Crystals and Liquid Crystals. 152: 89-104, 1987.
[Journal]
233)  Dimitrov DS.
Approach and instability of membranes: Physiocochemical mechanisms and applications to adhesion, fusion, dielectrophoresis, electroporation and liposome formation.
Proc. 8th School on Biophysics of Membrane Transport. 51-82, 1986.
[Journal]
234)  Stoicheva N, Dimitrov DS.
Dielectrophoresis of myeloma cells, hybridomas and B lympohcytes.
Proc. Bulg. Acad. Sci. 39: 105-07, 1986.
[Journal]
235)  Stoicheva N, Dimitrov DS.
Dielectrophoresis of single protoplasts: effects of increased conductivity caused by calcium ions.
Studia Biophys. 111: 17-21, 1986.
[Journal]
236)  Dimitrov DS, Zhelev D.
Dynamics and stability of membrane systems.
Int. Biotechnol. Lab. 4: 12-20, 1986.
[Journal]
237)  Dimitrov DS, Angelova M.
Dynamics of swelling and electroswelling of lipids: theory and experiment.
Studia Biophys. 113: 15-20, 1986.
[Journal]
238)  Stoicheva N, Dimitrov DS.
Frequency effects in protoplast dielectrophoresis.
Electrophoresis. 7: 339-41, 1986.
[Journal]
239)  Weiss L, Dimitrov DS.
Mechanical aspects of the lungs as cancer cell-killing organs during hematogenous metastasis.
J Theor Biol. 121: 307-21, 1986.
[Journal]
240)  Tsoneva IC, Zhelev DV, Dimitrov DS.
Red blood cell dielectrophoresis in axisymmetric fields.
Cell Biophys. 8: 89-101, 1986.
[Journal]
241)  Dimitrov DS, Zhelev D.
Dynamics of membrane stability and fusion.
Sudia Biophys. 110: 105-11, 1985.
[Journal]
242)  Ivanov IB, Dimitrov DS, Jain RK, Somasundaran P.
General formulation of the theory of formation and thinning of wetting and foam films with deformable surfaces.
Chem Eng. Sci. 40: 137-50, 1985.
[Journal]
243)  Stoicheva N, Tsoneva I, Dimitrov DS, Panaiotov I.
Kinetics of calcium-induced fusion of cell-size liposomes with monolayers in solutions of different osmolarity.
Z Naturforsch [C]. 40: 92-6, 1985.
[Journal]
244)  Weiss L, Dimitrov DS.
Metastasis peculiarities, metastasis inefficiency and mechanical destruction of cancer cells in lung microcirculation.
Oncology. 23: 1-6, 1985.
[Journal]
245)  Stoicheva N, Tsoneva I, Dimitrov DS.
Protoplast dielectrophoresis in axisymmetric fields.
A. Naturforsch. 40: 735-39, 1985.
[Journal]
246)  Dimitrov DS, Zhelev DV, Jain RK.
Stability of membrane systems modeled as multilayered viscoelastic films.
J Theor Biol. 113: 353-77, 1985.
[Journal]
247)  Zhelev DV, Dimitrov DS.
Stability of membrane systems modeled as thin films: Applications to membrane adhesion and fusion.
Int. Agrophysics. 1(2): 205-17, 1985.
[Journal]
248)  Dimitrov DS, Angelova M.
Surface and electric field effects in preparation of cell-size liposomes.
Proc. Biotech. 85(1): 655-60, 1985.
[Journal]
249)  Weiss L, Dimitrov DS, Angelova M.
The hemodynamic destruction of intravascular cancer cells in relation to myocardial metastasis.
Proc Natl Acad Sci U S A. 82: 5737-41, 1985.
[Journal]
250)  Weiss L, Dimitrov DS.
A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis.
Cell Biophys. 6: 9-22, 1984.
[Journal]
251)  Dimitrov DS, Stoicheva N, Stefanova D.
A simple interpolation formula for the rate of approach of particles or cells with tension-controlled shape at artitrary separations.
J. Colloid Interface Sci. 98: 269-71, 1984.
[Journal]
252)  Dimitrov DS, Tsoneva I, Stoicheva N, Zhelev D.
An assay for dielectrophoresis: Applications to electromagnetically induced membrane adhesion and fusion.
J. Biol. Phys. 12: 26-30, 1984.
[Journal]
253)  Dimitrov DS.
Dynamics of longitudinal deformations of monolayers from membrane components.
J. Phys. Chem. 59: 458-63, 1984.
[Journal]
254)  Dimitrov DS.
Electric field-induced breakdown of lipid bilayers and cell membranes: a thin viscoelastic film model.
J Membr Biol. 78: 53-60, 1984.
[Journal]
255)  Tsoneva I, Zhelev DV, Dimitrov DS.
Electromagnetic fusion of membranes in cell dielectrophoresis.
Proc. 35th Meeting Int. Sco. Electrochem. 1001-3, 1984.
[Journal]
256)  Stoicheva N, Tsoneva I, Dimitrov DS.
Fusion of giant liposomes with monolayers.
Proc. Acad. Bulg. Sci. 37: 1107-10, 1984.
[Journal]
257)  Dimitrov DS, Ivanov IB, Traykov TT.
Influence of permeability on the rate of mutual approach of membranes.
J. Membr. Sci. 17: 79-87, 1984.
[Journal]
258)  Dimitrov DS, Banarez R.
MEFES: A membrane fusion expert system.
Proc. Int. Conf. Artificial Intelligence, Microfische 2. Varna, BAN, 1984.
[Journal]
259)  Dimitrov DS, Jain RK.
Membrane stability.
Biochim Biophys Acta. 779: 437-68, 1984.
[Journal]
260)  Dimitrov DS, Zhelev D.
Stability of multi-layered thin liquid films: Applications to membrane systems.
J. Colloid Interface Sci. 99: 324-34, 1984.
[Journal]
261)  Dimitrov DS, Jain RK.
Stability of thin viscoelastic films between permeable membranes.
J. Colloid Interface Sci. 101: 489-99, 1984.
[Journal]
262)  Dimitrov D, Li J.
Surface effects in preparation of cell-size liposomes.
FEBS Lett. 176: 398-400, 1984.
[Journal]
263)  Mutafchieva R, Panaiotov I, Dimitrov DS.
Surface pressure hysteresis of mixed lipid/protein monolayers: applications to the alveolar dynamics.
Z Naturforsch [C]. 39: 965-72, 1984.
[Journal]
264)  Dimitrov DS, Stoilova S.
A hydrodynamic theory of bilayer membrane formation and some hypotheses about the mechanism of cell adhesion kinetics.
Studia Biophys. 90: 103-104, 1982.
[Journal]
265)  Dimitrov DS, Georgiev GA, Stoicheva NG, Traykov TT.
Dynamics of viscoelastic spherical membranes- the balloon model of the alveolus.
J Theor Biol. 96: 517-32, 1982.
[Journal]
266)  Dimitrov DS.
Instability of thin liquid films between membranes.
J. Colloid Polymer Sci. 260: 1137-44, 1982.
[Journal]
267)  Dimitrov DS.
A hydrodynamic theory of bilayer membrane formation.
Biophys J. 36: 21-5, 1981.
[Journal]
268)  Romero FJ, Pastor A, Lopez J, Romero PV.
A model of the viscoelastic behavior of the lung parenchymal uniaxial deformations.
Studia Biophys. 84: 145-46, 1981.
[Journal]
269)  Dimitrov DS, Georgiev G, Dimitrov AS.
Non-steady diffusion of gases through monolayers. I. Phenomenological description.
Studia Biophys. 85: 133-34, 1981.
[Journal]
270)  Dimitrov DS, Dimitrov AS, Georgiev G.
Non-steady diffusion of gases through monolayers. II. A cluster model.
Studia Biophys. 85: 135-36, 1981.
[Journal]
271)  Taneva S, Dimitrov DS, Panaiotov I.
Hysteretic cycles of the surface pressure of dipalmitoyllecithin monolayers.
Ann. Univ. Sofia Fac. Chem. 74: 73-81, 1980.
[Journal]
272)  Dimitrov DS, Georgiev G.
Kinetics of adsorption (or desorption) induced density change of a monolayer subjected to small deformations.
Studia Biophys. 78: 177-87, 1980.
[Journal]
273)  Panaiotov I, Dimitrov DS, Taneva S, Mutafchieva R, Vassilev P, Georgiev G.
Model investigations of the alvelar surface. VI. Dynamic behavior of the alveolar lining layer - Plane surface model.
Proc. II Int. Lung Lipid Metabolism, Mechanisms of its Regulation and Alveolar Surfactant. Sofia, Publishing House: 67-72, 1980.
[Journal]
274)  Dimitrov DS, Panaiotov I.
Model investigations of the alveolar surface. I. Elastic and viscoelastic behavior of dipalmitoyllecithin monolayers at small deformations.
Proc. II Int. Lung Lipid Metabolism, Mechanisms of its Regulation and Alveolar Surfactant. Sofia, Publishing House: 19-26, 1980.
[Journal]
275)  Tanevas S, Dimitrov DS, Panaiotov I.
Model investigations of the alveolar surface. II. Influence of the Maragoni effect, surface pressure relaxations and collapse on the surface pressure hysteresis of dipalmitoyllecithin monolayers.
Proc. II. Int. Lung Lipid Metabolism, Mechanisms of its Regulation and Alveolar Surfactant. Sofia, Publishing House: 27-31, 1980.
[Journal]
276)  Panaiotov I, Dimitrov DS.
Model investigations of the alveolar surface. III. Viscoelastic behavior and surface pressure hysteresis of serum albumin monolayers.
Proc. II Int. Lung Lipid Metabolism, Mechanisms of its Regulation and Alveolar Surfactant. Sofia, Publishing House: 48-53, 1980.
[Journal]
277)  Mutafchieva R, Panaiotov I, Dimitrov DS, Georgiev G.
Model Investigations of the alveolar surface. V. Equilibrium and dynamic properties of mixed binary monolayers formed by dipalmitoyllecithin, sphingomyelin and serum albumin.
Proc. II Int. Lung Lipid Metabolism, Mechanisms of its Regulation and Alveolar Surfactant. Sofia, Publishing House: 61-66, 1980.
[Journal]
278)  Dimitrov DS, Georgiev G, Valevski G.
Model investigations of the alveolar surface. VII. Dynamic behavior of the alveolar lining layer and the underlying lung tissue - Bubble model.
Proc. II Int. Lung Lipid Metabolism, Mechanisms of its Regulation and Alveolar Surfactant. Sofia, Publishing House: 73-80, 1980.
[Journal]
279)  Panaiotov I, Dimitrov DS, Georgiev G.
Viscoelastic relaxation in mixed dipalmitoyllecithin - serum albumin monolayers, modelling the lung surface film.
Studia Biophys. 78: 95-102, 1980.
[Journal]
280)  Panaiotov I, Dimitrov DS, Ter-Minassiam-Saraga L.
Dynamics of insoluble monolayers. II. Viscoelastic behavior and Marangoni effect for mixed protein phospholipid films.
J. Colloid Interface Sci. 72: 49-53, 1979.
[Journal]
281)  Dimitrov DS, Georgiev G, Valevski G.
Equilibrium and stability of the alveolar lining layer: A surface physical chemistry viewpoint. I. Thermodynamic treatment.
Studia Biophys. 77: 121-32, 1979.
[Journal]
282)  Dimitrov DS, Valevski G, Georgiev G.
Equilibrium and stability of the alveolar lining layer: A surface physical chemistry viewpoint. II. Hydrodynamic effects.
Studia Biophys. 77: 221-6, 1979.
[Journal]
283)  Panaiotov I, Dimitrov DS, Ivanova M.
Influence of bulk-to-surface diffusion interchange on dynamic surface tension excess at uniformly compressed interface.
J. Colloid Interface Sci. 69: 318-25, 1979.
[Journal]
284)  Dimitrov DS, Georgiev G, Valevski G.
Mechanical equilibrium and stability of elastic spherical membranes - the balloon model of the alveolus.
Studia Biophys. 77: 201-2, 1979.
[Journal]
285)  Ivanov IB, Dimitrov DS, Radoev BP.
The general dquation of the hydrodynamics of think liquid films and their application in calculation of the rate of thinning of thin films with non-deformable surfaces.
Colloid Zh. 41: 36-41, 1979.
[Journal]
286)  Dimitrov DS, Panaiotov I, Richmond P, Ter-Minassian-Saraga L.
Dynamics of insoluble monolayers. I. Dilational or elastic modulus, friction coefficient and Marangoni effect for dipalmitoyllecithin monolayers.
J. Colloid Interface Sci. 65: 483-94, 1978.
[Journal]
287)  Dimitrov DS, Ivanov IB.
Hydrodynamics of thin liquid films. On the rate of thinning of microscopic films with deformable interfaces and validity of the Reynolds law.
J. Colloid Interface Sci. 64: 97-106, 1978.
[Journal]
288)  Ivanov IB, Dimitrov DS, Radoev BP.
Hydrodynamics of thin liquid films. Rate of expansion of the perimeter of the three-phase contact line.
J. Colloid Interface Sci. 63: 166-68, 1978.
[Journal]
289)  Panaiotov I, Dimitrov DS, Ter-Minassian-Saraga L.
Propagation of longitudinal deformations along soluble and insoluble monolayers.
Ann. Univ. Sofia Fac. Chem. 72(1): 81-94, 1978.
[Journal]
290)  Dimitrov DS, Panaiotov I, Ivanova TS, Georgiev G.
Surface pressure relaxation of dipalmitoyllecithin monolayers.
Ann. Univ. Sofia Fac. Chem. 72(1): 119-130, 1978.
[Journal]
291)  Panaiotov I, Dimitrov DS, Ivanov M.
Investigation of the dynamic surface pressure of soluble adsorption layers.
Ann. Univ. Sofia Fac. Chem. 71(1): 89-100, 1977.
[Journal]
292)  Panaiotov I, Dimitrov DS, Ivanova M, Taneva S.
Longitudinal deformations of binary mixtures of soluble and insoluble adsorption layers.
Ann. Univ. Sofia Fac. Chem. 71(2): 27-40, 1977.
[Journal]
293)  Dimitrov DS.
The critical radium of disengagement of a small bubble from a rigid plane.
Proc. Bulg. Acad. Sci. 30: 269-70, 1977.
[Journal]
294)  Dimitrov DS, Panaiotov I.
A theoretical investigation of the dynamic surface pressure in the case of longitudinal deformaitons of viscoelastic monolayers.
Ann. Univ. Sofia Fac. Chem. 70(1): 115-122, 1976.
[Journal]
295)  Dimitrov DS.
Deformation of a draining film between a rigid sphere and a gas-lipid interface.
Proc. Bulg. Acad. Sci. 29: 1791-92, 1976.
[Journal]
296)  Dimitrov DS, Panaoitov I.
Hydrodynamic interaction between an insoluble elastic monolayer and a liquid support in Langmuir trough.
Ann. Univ. Sofia Fac. Chem. 70(1): 103-114, 1976.
[Journal]
297)  Radoev BP, Dimitrov DS.
Hydrodynamics of foam films stabilized by surfactants of low surface activity.
Proc. 7th Int. Congress Surface Active Subst. Moscot, Nauka: 473-79, 1976.
[Journal]
298)  Dimitrov DS, Radoev BP.
Hydrodynamics of foam fils in absence of surfactants.
Proc. Bulg. Acad. Sci. 29: 1649-51, 1976.
[Journal]
299)  Dimitrov DS, Ivanov IB.
Dydrodynamics of thin fils from noematic liquid crystals.
Proc. Bulg. Acad. Sci. 28: 1513-15, 1975.
[Journal]
300)  Dimitrov DS, Ivanov IB.
Dydrodynamics of thin liquid films. Rate of thinning of microscopic films with deformable surfaces and validity of the Reynolds law.
Ann. Univ. Sofia Fac. Chem. 69(1): 83-94, 1975.
[Journal]
301)  Podgórski A, Sosnowski TR, Gradon L.
Dynamic esasticity of pulsating gas bubble.
Ann. Univ. Sofia Fac. Chem. 69(1): 143-51, 1975.
[Journal]
302)  Dimitrov DS, Radoev BP.
Hydrodynamics of foam films in absence of surfactants.
Ann. Univ. Sofia Fac. Chem. 69(1): 33-44, 1975.
[Journal]
303)  Dimitrov DS, Ivanov IB.
Hydrodynamics of thin films from noematic liquid crystals.
Ann. Univ. Safia Fac. Chem. 69(1): 65-82, 1975.
[Journal]
304)  Dimitrov DS, Ivanov IB.
Mass transport in this liquid films.
Ann. Univ. Safia Fac. Chem. 69(2): 73-80, 1975.
[Journal]
305)  Radoev BP, Dimitrov D, Ivanov IB.
Hydrodynamics of thin liquid films. Effects of surfactants on the rate of thinning.
J. Colloid Polymer Sci. 252: 50-55, 1974.
[Journal]
306)  Ivanov IB, Dimitrov DS.
Hydrodynamics of thin liquid fils. Effect of surface viscosity on thinning and rupture of foam films.
J. Colloid Polymer Sci. 252: 982-90, 1974.
[Journal]
307)  Ivanov IB, Dimitrov DS, Radoev BP.
Hydrodynamics of thin liquid films. The rate of expansion of the perimeter of the three-phase contact line.
Ann. Univ. Sofia Fac. Chem. 67: 377-87, 1973.
[Journal]
308)  Ivanov IB, Dimitrov DS.
Hydrodynamics of thin liquid films. Influence of surface viscosity on the thinning and rupture of foam films.
Ann. Univ. Sofia. Fac Chem. 66: 655-72, 1972.
[Journal]
309)  Radoev BP, Dimitrov DS, Ivanov IB.
Hydrodynamics of thin liquid films. Influence of the surfactants on the rate of thinning.
Ann. Univ. Sofia Fac. Chem. 66: 87-98, 1972.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/22/2013.